Dehaier Medical Systems Limited (NASDAQ:DHRM)

Dehaier Medical Systems Limited is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier’s technology is based on five patents and five software copyrights; additionally, we have three pending patents and six pending software copyrights, and proprietary technology.

Dehaier Medical Systems’ revenue rose 12% to $2.95 million while net income came in at $0.21 million verses $0.52 million for the prior year period. DHRM also ended first quarter of 2011 with cash and cash equivalents of $3.37 million and working capital of $23.15 million. Dehaier Medical Systems has an earnings call scheduled for August 15, on Monday.

DHRM closed at $2.859, gained 3.59% on last trading day, with the 36,961 volume. It has 52-week low of $1.95 and high of $7.74. Previous Closing Price is below its 100 day moving average $3.44  and its 250 day moving average $4.60. It has an ongoing P/E of 2.72, which indicates that it seems highly undervalued. It is rated strong buy by stoxline.com and has a price target of $3.83 in six months.

About the Author

has written 14104 stories on this site.

Copyright © 2012 Nine Stocks